
Germany will reimburse haemophilia gene therapy Hemgenix
CSL Behring has added another major European market to the list of those providing reimbursement coverage of its haemophilia B gene therapy Hemgenix, after agreeing an access deal in Germany. The agreement with the GKV-Spitzenverband – the national …